Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMI
2023-503220-76-01Phase 4Authorised
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in recurrent miscarriage (RPL) comparing Prednisolone with Placebo (2 arms). Primary endpoint: Primary: Completion of follow-up and data collection. Planned start Oct 2023; status: authorised.
02
Drugs
prednisolone
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on 2023-503220-76-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503220-76-01.